Compliance Training Webinars for Regulated Industries

Everyone struggles with getting their laboratory into compliance. Learn how to build a compliant laboratory from starting with a good foundation to implementing for Business Excellence. Dr. Husman’s presentation will walk you through the process and steps needed to ensure a compliant laboratory is built or rebuilt for business excellence.

This webinar will discuss the risks in IV sterile compounding and how to mitigate those risks. We will review the safety requirements in USP <797> and USP <800>, to ensure the safe compounding of CSPs and protection of the patient and compounding staff.

The program will take the PPP and show step by step who is eligible, how to apply, the information required to apply, how much to apply for, what is included in payroll costs and the loan forgiveness features of the program. We will also discuss Emergency Economic Injury Disaster Loans (EEIDL).

Managers and leaders need to understand that a diverse workplace with women in upper management positions performs better than those companies that are less diverse. Women and minorities are not supported in some Company Cultures making it hard for them to reach upper levels. This presentation gives women and minorities three assertive communication models.

As the coronavirus outbreak continues to wreak havoc on markets and industries in the U.S. and around the world, businesses are now confronting significant and unique challenges. Successful navigation of these challenges will require thoughtful and comprehensive planning.

Interpersonal Communications Skills for Leaders can encompass may hours of formal classroom training. As such, this webinar will cover only several topics due to time constraints. This webinar is meant to introduce how interpersonal communication is the hallmark of a leader and how we may draw upon precise communication to further our agenda. When viewing interpersonal communication through the lens of leadership two wonderful things happen: one, the personals communication style is enhanced since they now have a new modality (that of leadership) to communicate through, and two, their leadership skills are enhanced since they have put new tools into their leadership toolbox.

The consequences of an immune response to biologicals, range from transient appearance of antibodies without any clinical significance to severe life-threatening conditions. Understanding why an immune response is generated, how to detect or predict its generation will help in designing products that will be efficacious and therapeutic.

Attend this webinar to understand the DHS temporary flexibility in the requirements for completing Form I-9, Employment Eligibility Verification, while employers are operating remotely. Learn how Employers can mitigate the changes and still stay compliant.

In response to the global coronavirus pandemic, the UK’s MHRA has published guidance designed to protect the drug supply chain. The scope of the guidance is far-reaching (see below for details) and includes temporary changes to GMP and GDP expectations as well as some licensing arrangements.

This training program will discuss a new employee’s role in his/her orientation and difference between orientation to the organization and orientation to the department. The program will also explain gap analysis, force field analysis, and SWOT analysis in assessing your organization’s onboarding requirements.

This program examines what is currently known about the coronavirus disease 2019 (COVID-19). COVID-19 is a respiratory illness that can spread from person to person. The outbreak first started in China, but the virus continues to spread internationally and in the United States. This webinar provides information from the CDC, the World Health Organization and OSHA which may help prevent workplace exposures to COVID-19, in non-healthcare settings. This program also provides planning considerations for home and community spread of COVID-19.

This webinar will focus on the proper steps for employers to take and employees to follow once the green light to return to work post-COVID is given. You will learn what experts say and what regulatory agencies require as we transition back to work.

This session will focus on conducting a risk/benefit analysis of both the positive and potential negative impact of the advancement of AI and ML devices in the medical device industry. It will provide a further understanding of the FDA's current thinking on the implementation of regulatory policies to ensure safe and effective medical devices that advance the quality of life of the patient. Artificial intelligence technology is rapidly spreading across the medical field, as systems are being developed that can identify signs of illness and disease in a wide variety of imaging situations such as MRI and CT. AI devices are complex with respect to algorithm used in their development, information being input in to the systems in which they learn, and the recommended out from such learning.

Although there are no official regs for cosmetic GMP’s, failure to maintain control of your operation can lead to severe regulatory consequences. You can avoid unwanted FDA oversight by maintaining cosmetic processes under control. One avoidable recall could result in a domino effect having tremendous negative impact on your organization.

The U.S. Food and Drug Administration’s is responsible for regulating the Over-the-Counter Drug market. In this webinar, attendees will learn what is required to market and sell an OTC drug in the U.S. It will provide information on what is an OTC drug, how they are regulated, the different types of products, how to read a Monograph, whether or not a certain ingredient can be used, the parts of a proper label, and a variety of other important requirements needed to be successful.

Applying Six Sigma techniques to laboratory practices increases efficiency, decreases waste and improves morale. This presentation will demonstrate how applying DOWNTIME can help improve the efficiency of lab service and function.

This webinar provides some practical and useful answers to the question: “What Strategies Should I Use to Speed Up Formulation Development?” A strategy based on QbD principles that have been proven to effectively and efficiently develop useful multi-component formulations is presented in this webinar. A critical goal is the creation of formulation understanding and design space that will consistently produce a product that meets specifications with minimal risk of failure. This strategy will be described and discussed along with several examples of its use.

Attend this webinar to learn how to recognize bias in your workplaces and take the necessary steps to reduce and address bias.

This course for pharmaceutical professionals provides the information they require, to prepare for and understand what will happen during a mock audit and during a Pre-Approval Inspection (PAI).

This webinar will explain the structure and timeline of a customs audit, and teach attendees how to successfully prepare for an audit. Attendees will learn the best practices for trade compliance and customs compliance that you can implement while importing/exporting to minimize penalties. Also you will learn how to establish a reasonable care process, identify the characteristic of internal controls along-with real life examples of implementing a compliance program successfully.